Our Covid-19 Test Kits
CTR Medical Supplies work closely with our partners across the globe to supply a full range of Covid19 test kits. These include Covid-19 antibody, saliva antigen, realtime PCR, neutralization, nasopharyngeal, vitamin D and influenza A&N antigen combo test kits as used by Government authorities worldwide.
We offer a range of Covid-19 test kits that are produced exclusively for CTR Medical Supplies by Softec UK & Ireland Zet Medical Distributors.
Our Konsung test kits are 3a Validated by the Medicines & Healthcare products Regulatory Agency (MHRA).
All our Covid-19 antibody and antigen test kits identify British SARS-CoV-2 variant virus (VUI-2020-12/01), and also offer the following benefits:
- Each Test Kit carries an individual & unique QR Code for Traceability on the Cassette
- Test kits are CE Certified with regulatory approval Germany & Italy
- Fast results in 20-30 minutes
- Safe and effective
- Accurate to 98.1%
- Delivery in 7 days for up to 250,000 sets
- Used by Government authorities worldwide
Genrui Novel Coronavirus (2019-nCoV) Nucleic Acid Total Solution
- Total Solution; Sample Collection, Nucleic Acid Extraction, Detection
- Reliable fully automatic extraction process
- Large touch screen and auto-ultraviolet disinfection module
- Rapid heating/cooling and excellent extraction performance
- User-friendly operation and many conveniences for the customer
- Principle: Auto magnetic bead extraction
- Extraction time 10-30min
Konsung Covid-19 Test Kits
Coronaviruses are enveloped RNA viruses that are distributed broadly among humans, other mammals, and birds and that cause respiratory, enteric, hepatic, and neurologic diseases. Seven coronavirus species are known to cause human disease. Four viruses – 229E, OC43, NL63, and HKU1 – are prevalent and typically cause common cold symptoms in immunocompetent individuals.4 The three other strains – severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and 2019 Novel Coronavirus (COVID-19) – are zoonotic in origin and have been linked to sometimes fatal illness. IgG and IgM antibodies to 2019 Novel Coronavirus can be detected 2-3 weeks after exposure. IgG remains positive, but the antibody level drops over time.
Main Symptoms of COVID-19
Common symptoms of COVID-19 infection include fever, fatigue, cough and respiratory symptoms like shortness of breath.
IgM and IgG are immunoglobulins produced by the immune system to provide protection against COVID-19 and can be detected in the serum, plasma or whole blood.
IgM: formed early in the immune response, normally appears 7 days of symptom onset.
IgG: appears later than IgM, IgG antibodies generally can be detected from 10 days of symptom onset and can last for months or even longer, remaining detectable in blood after the disease resolution.
Interpretation of Results for One Step Covid-19 IgG/IgM Antibody Test Kit (Colloidal Gold)
If only the C band is present, the absence of any burgundy colour in both T bands (IgG and IgM) indicates that no anti-COVID-19 antibodies are detected in the specimen. The result is negative.
In addition to the presence of C band, if only IgM band is developed, the test indicates the presence of IgM anti-COVID-19 in the specimen. The result is IgM anti-COVID-19 positive.
In addition to the presence of C band, if only IgG band is developed, the test indicates the presence of IgG anti-COVID-19 in the specimen. The result is IgG anti-COVID-19 positive.
IgG and IgM POSITIVE:
In addition to the presence of C band, both IgG and IgM bands are developed, the test indicates the presence of both IgG and IgM anti-COVID-19 in the specimen. The result is IgG and IgM anti-COVID-19 positive.
The Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test with a new test cassette.
On February 24th, Konsung Covid antigen and COVID-19 salivary antigen test kits successfully obtained the notice of admission from the Federal Institute for Drugs and Medical Devices (BfArM) Germany. This helps official German institutions carry out large-scale rapid screening of the coronavirus, to ensure public welfare, and assist safe returning to work and school.
SOFTEC SARS-COV2 (COVID-19) Antigen Rapid Test Kit
What is Sars Cov2 Antigen test kit?
The COVID-19 Antigen Rapid Test Cassette is a lateral flow immunoassay intended for the qualitative detection SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swab and oropharyngeal swab from individuals who are suspected of COVID-19 by their healthcare provider.
Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in nasopharyngeal swab and oropharyngeal swab during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.
Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary for patient management.
The COVID-19 Antigen Rapid Test Cassette is intended for use by trained clinical laboratory personnel specifically instructed and trained in vitro diagnostic procedures.
The novel coronaviruses (SARS-CoV-2) belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhoea are found in a few cases.
COVID-19 Antigen Rapid Test Cassette is an immunoassay based on the principle of the double antibody-sandwich technique. The COVID-19 Antigen Rapid Test Cassette is designed to detect nucleocapsid antigen from the SARS-CoV-2 in nasopharyngeal swab and oropharyngeal swab, from patients who are suspected of COVID-19 by their healthcare provider.
During testing, a specimen migrates upward by capillary action. The SARS-CoV-2 antigens if present in the specimen will bind to the antibody conjugates. The immune complex is then captured on the membrane by the pre-coated SARS-Co-2 nuclenocapsid protein monoclonal antibody, and a visible coloured line will show up in the test line region indicating a positive result. In the absence of SARS-CoV-2 antigens, a coloured line will not form in the test line region indicating a negative result.
To serve as a procedural control, a coloured line will always appear at the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.
SOFTEC SARS Cov-2 Ig G /Ig M Ab Rapid Test Kit (Covid-19)
The COVID-19 IgG/IgM Rapid Test Cassette is a lateral flow chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) to Novel coronavirus in human Whole Blood/Serum/Plasma. It provides an aid in the diagnosis of infection with novel coronavirus.
Coronaviruses are enveloped RNA viruses that are distributed broadly among humans, other mammals, and birds and that cause respiratory, enteric, hepatic, and neurologic diseases.Six coronavirus species are known to cause human disease. Four viruses-229E, OC43, NL63, and HKU1 are prevalent and typically cause common cold symptoms in immunocompetent individuals. The two other strains severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are zoonotic in origin and have been linked to sometimes fatal illness.
Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.
Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.
ABOUT SOFTEC SARS Cov-2 Ig G /Ig M Ab Test Kit (Covid-19)
The COVID-19 IgG/IgM Rapid Test Cassette is a qualitative membrane strip based immunoassay for the detection of antibodies (IgG and IgM) to Novel coronavirus in human Whole Blood/Serum/Plasma. The test cassette consists of: 1) a burgundy coloured conjugate pad containing Novel coronavirus recombinant envelope antigens conjugated with Colloid gold (Novel coronavirus conjugates), 2) a nitrocellulose membrane strip containing two test lines (IgG and IgM lines) and a control line (C line). The IgM line is pre-coated with the Mouse anti-Human IgM antibody, IgG line is coated with Mouse anti-Human IgG antibody. When an adequate volume of the test specimen is dispensed into the sample well of the test cassette, the specimen migrates by capillary action across the cassette. IgM anti-Novel coronavirus, if present in the specimen, will bind to the Novel coronavirus conjugates.
The immunocomplex is then captured by the reagent coated on the IgG line, forming a burgundy coloured IgG line, indicating a Novel coronavirus IgG positive test result. The absence of any T lines (IgG and IgM) suggests a negative result. To serve as a procedural control, a coloured line will always appear at the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.
Why Choose Us
Join Our Mailing List : Receive Special Offers and Updates!
Frequently Asked Questions
- PPE are designed to create a non-disease specific barrier to penetration of substances, solid, liquid, or airborne particles. In general, neither FDA nor the manufacturer can provide assurances that PPE will protect you against a specific disease. The data that FDA uses for the evaluation and clearance of PPE rarely includes performance evaluation or testing against specific viruses, such as Ebola or flu. If performance data has met FDA requirements and demonstrate protection against a specific disease, the product labeling will state the claim for protection against a specific virus or bacteria.When there is an outbreak that affects the broad population, The Centers for Disease Control and Prevention (CDC), is responsible for making specific recommendations for infection control measures in different circumstances and settings.
In general, most PPE is designed to be used only one time and by one person prior to disposal. There are a few exceptions, for example, some types of elastomeric respirator masks and protective eyewear such as goggles may be reused if the user follows decontamination methods in the product labelling.
We offer a full range of washable and re-usable Cotton & Polyester Masks which can be supplied with Disposable FFP3-11R pleated Liners providing 98.9 Filtration Or supplied with FFP-1 Civil Liner which provide at least 80% filtration. If you would like information regarding this please contact us .
If PPE is exposed to infectious materials during use (e.g., body fluids from an infected person) the PPE is considered contaminated and the wearer should remove it promptly, using proper removal and disposal procedures. Please be aware that even if a PPE successfully protects you while it is being worn, improper removal and disposal of contaminated PPEs can expose the wearer and other people to infectious agents.
PPE is designed to be used with other infection control practices such as hand-washing, using alcohol-based hand sanitizers and covering coughs and sneezes to minimize the spread of infection from one person to another.
Wearers of PPE can determine what protective level a PPE is rated for by the standards to which it has been tested.
CDC’s National Institute for Occupational Safety and Health (NIOSH) maintains a database called NIOSH Personal Protective Equipment Information (PPE-Info) that includes most of the current PPE standards in more detail.